Data / Drug companies / Cambrex Charles City, Inc
Cambrex Charles City, Inc: 114 products in the FDA NDC directory, labeler code 59116
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cambrex Charles City, Inc (labeler code 59116) lists 114 products in the FDA National Drug Code Directory. By type: 114 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 13, 2023.
The request: Watch Cambrex Charles City, Inc (FDA labeler code 59116): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 59116
- Products in commercial distribution
- 114
- Packages
- 114
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule II 39, Schedule III 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- October 26, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 114 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 114 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 113 | 99.1% |
| Liquid | 1 | 0.9% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Azd9833 | 59116-7280 | Powder | Bulk ingredients | June 13, 2023 |
| Cln-081 | 59116-7160 | Powder | Bulk ingredients | May 22, 2023 |
| S225ss milled | 59116-7270 | Powder | Bulk ingredients | March 20, 2023 |
| Tak-018 | 59116-7030 | Powder | Bulk ingredients | November 18, 2022 |
| Ndi-034858 | 59116-6910 | Powder | Bulk ingredients | November 18, 2022 |
| Tak-279 | 59116-0691 | Powder | Bulk ingredients | November 18, 2022 |
| Methylphenidate hydrochloride | 59116-6850 | Powder | Bulk ingredients | June 28, 2022 |
| Calcium oxybate | 59116-5970 | Powder | Bulk ingredients | March 31, 2022 |
| Utenpanium chloride | 59116-6870 | Powder | Bulk ingredients | February 1, 2022 |
| Flibanserin | 59116-6640 | Powder | Bulk ingredients | January 4, 2022 |
| Acoramidis hcl milled | 59116-5911 | Powder | Bulk ingredients | December 30, 2021 |
| Acoramidis hcl | 59116-5910 | Powder | Bulk ingredients | December 30, 2021 |
| Filgotinib maleate | 59116-7110 | Powder | Bulk ingredients | December 16, 2021 |
| Magnesium oxybate | 59116-5980 | Powder | Bulk ingredients | December 14, 2021 |
| Potassium oxybate | 59116-5960 | Powder | Bulk ingredients | December 14, 2021 |
| Sodium oxybate | 59116-5950 | Powder | Bulk ingredients | December 14, 2021 |
| Sdx | 59116-7530 | Powder | Bulk ingredients | March 2, 2021 |
| Trilaciclib dihydrochloride dihydrate | 59116-6360 | Powder | Bulk ingredients | February 12, 2021 |
| Remdesivir | 59116-6490 | Powder | Bulk ingredients | October 15, 2020 |
| Remdesivir | 59116-6490 | Powder | Bulk ingredients | October 15, 2020 |
| Ck-3773274 | 59116-6280 | Powder | Bulk ingredients | April 6, 2020 |
| Filgotinib maleate | 59116-5440 | Powder | Bulk ingredients | April 1, 2020 |
| Alxn2040 | 59116-6970 | Powder | Bulk ingredients | March 4, 2020 |
| Ripretinib | 59116-5333 | Powder | Bulk ingredients | February 24, 2020 |
| Ripretinib | 59116-5332 | Powder | Bulk ingredients | February 24, 2020 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.